Clinical & Epidemiological Studies

56
Clinical & Epidemiological Studies: Health Measures of Prebiotic Success Cyril W.C. Kendall Department of Nutritional Sciences, Faculty of Medicine, University of Toronto; Clinical Nutrition & Risk Factor Modification Center, St. Michael’s Hospital; Toronto, Ontario Canada.

Transcript of Clinical & Epidemiological Studies

Page 1: Clinical & Epidemiological Studies

Clinical & Epidemiological Studies: Health Measures of Prebiotic Success

Cyril W.C. Kendall

Department of Nutritional Sciences, Faculty of Medicine, University of Toronto;

Clinical Nutrition & Risk Factor Modification Center, St. Michael’s Hospital;

Toronto, OntarioCanada.

Page 2: Clinical & Epidemiological Studies

Fiber Hypothesis

Dr. Dennis Burkitt (observational studies in Africa)

• African diet - ↑ fiber & ↓ fat •↑ stool output•↓ chronic disease (cancer, heart disease diabetes)

Page 3: Clinical & Epidemiological Studies

Traditional,DevelopingCountries

Modern,Developed Countries

Page 4: Clinical & Epidemiological Studies

Current Problem Chronic Diseases

Metabolic Syndrome

Diabetes

CHD

Waist CircumferenceBPDisglycemiaInflammation

Page 5: Clinical & Epidemiological Studies

Fiber and Colon & Breast Cancers

Human Studies (↑ fiber & ↓ fat)

Population Studies- Finland, Scotland, USA - ↑ incidence

- Latin America, Africa, Japan - ↓incidence

Migrating Populations- Japanese (Japanese, Hawaii, USA)

Case-Control Studies

Page 6: Clinical & Epidemiological Studies

Fiber and Colon Cancer

High Fiber Diets•↑ fecal bulk (dilution effect)•↓ transit time (↓ contact time)• promote healthy bacteria•↓ secondary bile acid concentrations•↑ butyrate concentrations

Page 7: Clinical & Epidemiological Studies

Fiber and Colon Cancer

Human Studies (prospective)

61,463 healthy Swedish women (~10y follow-up)●↑ fruit & vegetable intake - ↓ CRC development●↓ cereal fiber intake – no effect

(Terry et al. J Natl Canc Inst 2001)

88,757 American women (16 y follow-up)●↑ dietary fiber (cereal, fruit or vegetable) – no effect on

development of CRC or adenomas (Fuchs et al. N Engl J Med 1999)

Page 8: Clinical & Epidemiological Studies

Fiber and Colon Cancer

Human Studies (intervention – high risk groups)

1,905 subjects followed for ~4 years - adopting a diet low in fat & high in fiber, fruit and vegetables did not influence recurrence of CRC adenomas (Schatzkin et al. N Engl J Med 2000)

1,303 subjects followed for ~3 years- wheat bran fiber (13 g/d) did not protect from recurrent CRC adenomas (Alberts et al. N Engl J Med, 2000)

Page 9: Clinical & Epidemiological Studies

Breast Cancer

Risk Factors (population studies)

- ↑ estrogen (early menses, late 1st pregnancy, late menopause)

- ↑ body weight- ↓ physical activity- ↑ fiber & ↓ fat diets- ↓ fruit & vegetable intakes

Page 10: Clinical & Epidemiological Studies

Fiber and Breast Cancer

High Fiber Diets•↑ estrogen excretion•↓ circulating estrogen levels

• flavonoids (anti-estrogens)

Page 11: Clinical & Epidemiological Studies

Fiber and Breast Cancer

Human Studies (prospective)

Nurses’ health Study followed for ~10 years ● HRT - ↑ breast cancer risk

(Colditz et al. N Engl J Med 1995)

Combined Prospective Studies ●↑ fiber & ↓ fat – no effect

(Willett. Cancer 1994)

Page 12: Clinical & Epidemiological Studies

Fiber and Breast Cancer

Human Studies (intervention – high risk groups)

291 women followed for ~1 year ● adopted a diet low in fat & high in fiber,

fruit and vegetables. - ↓ circulating estrogen levels

(Rock et al. J Clin Oncol, 2004)

Page 13: Clinical & Epidemiological Studies

Significant Scientific Agreement on Fiber

• Dietary guidance on increasing fiber (cereal grains, vegetables, fruits) – Recommend 25-38 g/d DF– Usual dose only 15 g

• Laxation benefits – High fibre cereals/bulk laxative

• Body Weight Control– High fibre diets associated with lower body weight

• Cholesterol lowering effects– Health claims for oat bran, psyllium, B-glucan

Page 14: Clinical & Epidemiological Studies

Wheat Bran & Colonic FunctionMetabolic Study (n=23): • Randomized controlled crossover study • 4 week treatments (breads & breakfast cereals).• Control Diet • + 19 g/d fiber WB - Fine particle size (50 um) • + 19 g/d fiber WB - Medium particle size (735 um) Ad Libitum Study (n=24):• Randomized controlled crossover study • 4 week treatments (breads & breakfast cereals).• Control Diet • + 17 g/d fiber WB – Medium (692 um) • + 17 g/d fiber WB - Coarse (1158 um)

Jenkins DJ, Kendall CW et al. J Am Coll Nutr 1999.

Page 15: Clinical & Epidemiological Studies

Fiber and Colonic Health

Jenkins DJ, Kendall CW et al. J Am Coll Nutr 1999.

Page 16: Clinical & Epidemiological Studies

Wheat Bran: Fecal & SCFA Output

Control Wheat Bran Wheat BranMedium Fine

Fecal (g/d) 211+23a 279+23b 268+23b

Total SCFA 24.7+3.1a 32.4+3.0b 35.3+3.5b

(mmol/d)

Acetate 12.5+1.8a 16.1+1.9a,b 18.1+2.0b

Propionate 3.1+0.5a 3.8+0.4a,b 4.4+0.5b

Butyrate 3.4+0.5a 4.8+0.6b 5.9+0.8c

Jenkins DJ, Kendall CW et al. J Am Coll Nutr 1999.

Page 17: Clinical & Epidemiological Studies

Wheat Bran: Fermentation Breath Hydrogen

Page 18: Clinical & Epidemiological Studies

What is a Heart-Healthy Diet?

National Cholesterol Education Program (ATP III): • 25-35% total fat• <7% saturated fat; <10% PUFA; <20% MUFA • <200 mg dietary cholesterol• 20-30 g/d fiber• healthy whole foods (whole grains, fruit & vegetables)

• viscous (soluble ) fiber (10-25 g/d)• plant stanol/sterols (2 g/d)• nuts – source of healthy fat,

fiber (AHA, 2000)

• soy protein – high risk individuals (AHA, 2000)

(JAMA, 2001)

Page 19: Clinical & Epidemiological Studies

Each Additional g of Fiber in the Diet Reduces CHD Risk

• Men– 6 g/d 24%

CHD (Khaw&Barrett-Connor, 1987)

– 10 g/d 29%

CHD (Rimm et al, 1996)

• Women– 6 g/d 33%

CHD (Khaw&Barrett-Connor, 1987)

– 5 g/d 37%

CHD (Wolk et al, 1999)

– 14g/d 54%

MI (Liu et al., 2002)

• Meta-analysis - 10g/d

27%

CHD death (Pereira et al. 2004)

Page 20: Clinical & Epidemiological Studies

Serum Lipid Response to a Diet Very High in Fiber From

Vegetables and Fruit (Simian Diet)

• Low-fat therapeutic diet (NCEP Step 2)low-fat dairy, white rice, potato, fruit & vegetables (5 servings/d)

• High-fiber starch-based (Neolithic)low-fat yogurt, whole grains, lentils, fruit & vegetables (5 servings/d)

• High-fiber vegetable-based (Simian)63 servings/d fruit & vegetables, nuts

Page 21: Clinical & Epidemiological Studies

Daily Intakes of Vegetable Protein, Fiber, Phytosterols & Nuts

NCEP Step 2 High-FiberStarch-Based

High-FiberVegetable-Based

Simian

Vegetable Protein (g/d) 28 64 93

Total Dietary Fiber (g/d) 26 46 143

Phytosterols (g/d)

Nuts (g/d)

0.3

0

0.5

0

1.0

84

Page 22: Clinical & Epidemiological Studies

Serum Lipid Response to a Diet Very High in Fiber From Vegetables and Fruit (Simian Diet)

Jenkins DJ, Kendall CW et al. Metabolism;(2001)

-40

-35

-30

-25

-20

-15

-10

-5

0

5

% C

hang

e fr

om B

asel

ine

LDL-cholesterol

Week 0 1 2

-40

-35

-30

-25

-20

-15

-10

-5

0

5

NCEP Step II

Neolithic

Simian

LDL:HDL-cholesterol

Week 0 1 2

Page 23: Clinical & Epidemiological Studies

The Simian Diet

5.5 kg food in

1.0+ kg feces out & 1g bile acids

Page 24: Clinical & Epidemiological Studies

Simian Diet & Colonic Microflora Concentration

Anaerobes Aerobes Anaer/Aer Bifido Bacteroides Fusobacteria

Page 25: Clinical & Epidemiological Studies

Simian Diet & Colonic Microflora Daily output

Page 26: Clinical & Epidemiological Studies

Portfolio Diet

Study Foods:Readily available in supermarkets.

Viscous Fiber: ~20 g/doats, barley, psyllium, legumes, eggplant, okra

Vegetable Protein: ~80 g/dsoy, beans, chick peas, lentils

Plant Sterols: ~2 g/dplant sterol margarine (1g/1000 kcal)

Nuts: ~30 g/dalmonds

Jenkins DJ, Kendall CW et al. Metabolism 2002

Page 27: Clinical & Epidemiological Studies

PORTFOLIOWeek 4 Mean ± SEM

Energy (kcal/d) 2421 ± 138 2519 ± 176 2383 ± 162

Total Protein (% calories) 20.6 ± 0.5 19.9 ± 0.7 20.2 ± 0.5

Vegetable Protein (% calories) 4.0 ± 0.1 4.2 ± 0.2 19.8 ± 0.5

Available Carbohydrate (% calories) 57.9 ± 1.8 59.6 ± 2.1 57.5 ± 2.3

Total Dietary Fiber (g/1000kcal) 21.9 ± 1.0 21.6 ± 1.0 31.1 ± 1.0

Total Fat (% calories) 22.9 ± 0.7 23.5 ± 0.8 28.0 ± 1.0

SFA (% calories) 4.2 ± 0.1 4.3 ± 0.2 5.9 ± 0.2

MUFA (% calories) 9.6 ± 0.4 9.4 ± 0.3 11.9 ± 0.7

PUFA (% calories) 7.9 ± 0.3 8.7 ± 0.4 9.4 ± 0.2

Dietary Cholesterol (mg/1000kcal) 10.9 ± 0.2 11.7 ± 0.8 21.2 ± 1.5

Alcohol (% calories) 0.1 ± 0.1 0.0 ± 0.0 0.4 ± 0.1

Satiety (-4 to +4) 2.3 ± 0.4 2.4 ± 0.3 2.8 ± 0.2

STATINCONTROLDiet

(n=16) (n=14)

(Test) Diet

(n=16)

Diet

Portfolio Diet #3: Results

Page 28: Clinical & Epidemiological Studies

Portfolio Study #3a: Results Changes in LDL-C (n=46)

-40

-35

-30

-25

-20

-15

-10

-5

0

5

10 LDL Cholesterol

Control

PortfolioStatin

Wk 0 Wk 2 Wk 4

% C

hang

e Fr

om B

asel

ine

Jenkins DJ, Kendall CW et al. JAMA 2003.

Page 29: Clinical & Epidemiological Studies

Portfolio Diet #3: Results Changes in C-Reactive Protein (n=46)

% C

hang

e Fr

om B

asel

ine

Wk 0 Wk 2 Wk 4

-40

-35

-30

-25

-20

-15

-10

-5

0

5

10 C-reactive Protein

Control

Statin

Portfolio

Jenkins DJ, Kendall CW et al. JAMA 2003

Page 30: Clinical & Epidemiological Studies

% LDL-C and % HDL-C

*

*, ** *, **

-25.0

-20.0

-15.0

-10.0

-5.0

0.0

5.0

10.0

Baseline End of Year 1 End of Year 2 End of Year 3

% C

hang

e

% LDL-C% HDL-C

Mean ± SE percentage change in LDL-C and HDL-C at end of each year n = 66). * and ** represent significant differences from baseline and year 1 respectively (P < 0.01).

Intent-to-Treat Analysis (n=66)

* * *4.8%

-6.9%-7.6%

-13.5%

4.1%3.4%

Page 31: Clinical & Epidemiological Studies

Changes from baseline in blood pressure

SBP - n = 28

120.3785714

**, **

*

100

105

110

115

120

125

Y0 Y1 Y2 Y3

SBP

DBP - n = 28

**

62

64

66

68

70

72

74

76

Y0 Y1 Y2 Y3

DBP

Page 32: Clinical & Epidemiological Studies

Antibiotics & Cholesterol Reduction: Colonic Microflora and LDL-cholesterol

Page 33: Clinical & Epidemiological Studies

Antibiotics & Cholesterol Reduction: Colonic Microflora and LDL-cholesterol

Page 34: Clinical & Epidemiological Studies

Antibiotics & Cholesterol Reduction: Colonic Microflora and LDL-cholesterol

Jenkins, Kendall et al., Metabolism (2005)

Page 35: Clinical & Epidemiological Studies

Inulin and Lipids

P<0.005

P<0.02

Davidson et al. 1998 Nutr Res 18:503-17.

Page 36: Clinical & Epidemiological Studies

Does ↑ FOS and Soy

= ↑ Isoflavone/Aglycone &Equol Synthesis?

= ↓ Cholesterol?

BIOTRANSFORMATION

Page 37: Clinical & Epidemiological Studies

Equol Production

Daidzein

Equol

Carbohydrate Fermentation

↓ LDL

Colonic Microflora

Page 38: Clinical & Epidemiological Studies

Equol Production: CHO Fermentation

In vitro metabolism of daidzein in a colonic model of fermentation of human fecal flora showing the influence of a high CHO milieu on the rate of conversion of daidzein to the intestinal bacterially derived metabolite equol.

Cassidy, 1991

Page 39: Clinical & Epidemiological Studies

Mean LDL Cholesterol

FOS control soy control FOS & soy

N = 23

* Significantly different from FOS control, P<0.05.

Mean LDL Cholesterol

-10

-8

-6

-4

-2

0

2

4

6

0 2& 4

Weeks

% c

hang

e fr

om b

asel

ine

*

Page 40: Clinical & Epidemiological Studies

Mean LDL:HDL cholesterol

FOS control soy control FOS & soy

N = 23

* Significantly difference from FOS control, P<0.05.

Mean LDL:HDL cholesterol

-12-10

-8-6-4-202468

10

0 2& 4

Weeks

% c

hang

e fr

om b

asel

ine

*

Page 41: Clinical & Epidemiological Studies

Hyperglycemia (high 2-h blood glucose or HbA1c) is associated with all-cause and CVD mortality

in non-diabetic populations

• Helsinki Policeman Study (Pyorala et al. 1979)• The Framingham Study (Singer et al. 1980)• The Whitehall Study (Fuller et al. 1983)• The Chicago Heart Study (Pan et al. 1986)• The Rancho Bernardo Study (Park et al. 1996; Barrett-Connor et al., 1998)• Hoorn study (De Vegt et al. Diabetologia, 1999)• ARIC study (Vitelli et al. 1997)•• MetaMeta--analysis analysis DECODE study (Lancet 1999)• EPIC-Norfolk (Khaw et al. 2001)• The Cardiovascular Health Study (Smith et al. 2002)•….many more now

Page 42: Clinical & Epidemiological Studies

Metabolic Effects

Low vs. High GI Foods:

Page 43: Clinical & Epidemiological Studies

Delayed Absorption

Delayed Absorption

Colonic FermentationColon

Small Intestine

Page 44: Clinical & Epidemiological Studies

0

5

10

15

20

0 5 10 15 20 25 30 35Fiber per 80 g carbohydrate portion (g)

Car

bohy

drat

e lo

sses

(g)

romano beans

kidney beans

chick peas

oat branbarley

lentils

pumpernickelb

bread

pumpernickela

breadwholemeal bread

long grain rice

bulgur

rye bread

rice chexcorn chex

spaghettiwhite bread

macaroni instant potatoinstant rice

parboiled rice

Page 45: Clinical & Epidemiological Studies

0

50

100

150

0 5 10 15 20 25

% Carbohydrate malabsorbed

Gly

cem

ic in

dex,

pub

lishe

d va

lues

rice chex

instant potatocorn chex

wholemeal breadwhite bread

oat branbulgur

rye bread

canned romano beans

canned chick peaslentils

pearl barleycanned kidney beans

Dimpflmeier pumpernickel breadKasseler pumpernickel bread

macaroni

long grain rice

spaghettiparboiled rice

instant rice

Page 46: Clinical & Epidemiological Studies

Salmeron et al. JAMA 1997;277:472-7

Glycemic Load and Cereal Fiber Intake in Women at Risk of Type 2 Diabetes

Page 47: Clinical & Epidemiological Studies

Sluijs et al. Am J Clin Nutr 2010

Dietary CHO Quantity and Quality and Risk of Type 2 Diabetes

EPIC NL Study ~ 40,000 subjects

Diabetes Cases (915)Increased risk – diets high in glycemic load,

glycemic index, total CHO,

starch

Decreased risk – diets high in fiber

Page 48: Clinical & Epidemiological Studies

% -35 -25 -15 -5 5 15

Gilbertson et al. 2001Komindr et al. 2001Giacco et al 2000Luscombe et al 1999Jarvi et al 1999Lafrance et al 1998Frost et al 1993Wolever et al 1992Wolever et al 1992Fontvieille et al 1992Brand et al 1991Jenkins et al 1991Fontvieille et al 1988Collier et al 1988

Mean %difference in 14 studies = Mean %difference in 14 studies = --7.4% (CI 7.4% (CI --8.8 to 8.8 to --6.0%)6.0%)

OVERALL RESULTOVERALL RESULT

Brand-Miller et al, Diabetes Care 2003;26:2261-67

Low vs High GI Diet: a Meta-Analysis % Difference in Glycated Proteins

Page 49: Clinical & Epidemiological Studies

Bran flakesOatmeal

Whole wheat crackersBulgur

Vegetable soupBeans, Chickpeas, Lentils

Whole wheat breadPumpernickel bread (Dimpflmeier)

Rye crackersBarley

Shredded WheatRed River cereal

White / Brown riceParboiled rice

Potato (baked, mashed)Pasta (al dente)

High Cereal Fiber Diet (Control)

Low GI Diet (Test)

Bran flakesOatmeal

Whole wheat crackersBulgur

Vegetable soupBeans, Chickpeas, Lentils

Whole wheat breadPumpernickel bread (Dimpflmeier)

Rye crackersBarley

Shredded WheatRed River cereal

White / Brown riceParboiled rice

Potato (baked, mashed)Pasta (al dente)

High Cereal Fiber Diet (Control)

Low GI Diet (Test)

GI < 70 GI = 80

Recommended Study Foods

Page 50: Clinical & Epidemiological Studies

0 4 8 12 16 20 24

Week

6.306.406.506.606.706.806.907.007.107.207.30

HbA

1c (%

)

Low Glycemic Index

High Cereal Fiber

Jenkins DJ, Kendall CW et al. JAMA 2008.

P<0.001

Low Glycemic Index Diets and Diabetes Control

Page 51: Clinical & Epidemiological Studies

Low Glycemic Index

High Cereal Fiber

Jenkins DJ, Kendall CW et al. JAMA 2008.

P=0.022

Low Glycemic Index Diets and Diabetes Control

0 2 4 8 12 16 20 24

Week

114

118

122

126

130

134

138

142

146

Fast

ing

gluc

ose

(mg/

dL)

Page 52: Clinical & Epidemiological Studies

0 2 4 8 12 16 20 24

Week

8081828384858687888990

Bod

y w

eigh

t (kg

)

Low Glycemic Index

High Cereal Fiber

Jenkins DJ, Kendall CW et al. JAMA 2008.

P=0.053

Low Glycemic Index Diets and Diabetes Control

Page 53: Clinical & Epidemiological Studies

Diastolic BP

68

70

72

74

76

Dia

stol

ic B

P (m

mH

g)

Low Glycemic Index

High Cereal Fiber

0 2 4 8 12 16 20 24

Week

Page 54: Clinical & Epidemiological Studies

Plasma SCFA´s vs. B-glucose AUC, insulin AUC and fasting serum FFA

with a standardised breakfastPlasma SCFA

Glucose AUC 0-120 min

Insulin AUC 0-120 min

Fasting p-FFA

r p r p r pFasting Butyrate -0.30 0.006 -0.19 0.046 -0.09 0.36

Propionate -0.08 0.46 -0.12 0.24 -0.07 0.49

Acetate -0.15 0.16 -0.01 0.89 0.14 0.14

30 min Butyrate -0.23 0.009 -0.08 0.44 -0.22 0.056

Propionate -0.16 0.13 0.08 0.37 -0.05 0.62

Acetate -0.12 0.28 -0.06 0.61 -0.07 0.46

Courtesy of Inger Bjorck

Page 55: Clinical & Epidemiological Studies

Overview• High fiber diets improve laxation and

gastrointestinal health.• Wheat bran and other particulate fibers are to

some extent fermented. • In large cohort studies high fiber intakes, which

is predominantly wheat bran in North America, are associated with reduced risk of cardiovascular disease and diabetes.

• Both insoluble and soluble fibers may produce metabolic advantages other than the traditional markers of cholesterol lowering and blunting postprandial glucose.

Page 56: Clinical & Epidemiological Studies

Thank you for your attention